Lineage Cell Therapeutics is a leader in pluripotent cell product development and lineage derivation protocols. Pluripotent cells, which are widely published as capable of being induced to become any cell type of the human body, have many potential applications in medicine. Our objective is to develop new treatments for conditions with large unmet patient needs, including certain age-related degenerative diseases and other serious medical conditions for which there presently are no cures or few treatment options.
Unlike pharmaceuticals that require a molecular target, cellular therapies are often aimed at regenerating or replacing affected or absent cells and/or improving bodily functions such as immune surveillance. Therefore, cellular therapies may be shown to have broader or more suitable applicability than many pharmaceutical products available today. Small molecules and biologic therapies that require systemic delivery into the body often have unexpected results, or side effects, that can limit their usefulness. Cell replacement to the eye or spinal cord is locally administered, so systemic side effects are usually not a major concern. For systemic administration of cells, the risk profile more closely resembles that of transplant medicine, focused more on whether the transplanted cells are rejected by the body and whether the cells function as expected.